Fred Eshelman
Principal
Wilmington, United States
7 investmentsFred Eshelman is a Principal based in Wilmington, United States. Fred Eshelman has backed 7 companies, including Cellective BioTherapy, Dignify Therapeutics and G1 Therapeutics. Investment focus areas include Health Care, Women Founded and Information Technology (IT).
Sign up to access email, LinkedIn & portfolio
Investment Focus
Portfolio Companies (7)
| Industry | Stage | Website | |||
|---|---|---|---|---|---|
| 1 | Cellective BioTherapy | — | — | — | — |
| 2 | Dignify Therapeutics | — | — | — | — |
| 3 | G1 Therapeutics | — | — | — | — |
| 4 | Kinnate Biopharma | — | — | — | — |
| 5 | Aruna Biomedical | — | — | — | — |
| 6 | Sapience Therapeutics | — | — | — | — |
| 7 | Innocrin Pharmaceuticals | — | — | — | — |
Showing 1–7 of 7
Access Full Contact Information
Get Fred Eshelman's email, LinkedIn, Twitter, full portfolio of investments, and export data to CSV.
Email
LinkedIn
Portfolio
No credit card required
Raising a round? Run your numbers first
Free tools founders use before pitching investors like this one.